Company · CIK 1903784

# Vogenx, Inc.

| CIK | [1903784](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001903784) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NC |
| Listed | VOGX (Nasdaq) |
| First annual or quarterly report | 2026-09-17 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-297487 | IPO Final prospectus | 2026-07-15 | 2026-08-12 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-08-12 | [424B4](https://www.sec.gov/Archives/edgar/data/1903784/000118518526003448/0001185185-26-003448-index.htm) Final prospectus | 333-297487 | 0001185185-26-003448 |
| 2026-08-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1903784/999999999526002615/9999999995-26-002615-index.htm) Declared effective | 333-297487 | 9999999995-26-002615 |
| 2026-08-10 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1903784/000118518526003353/0001185185-26-003353-index.htm) Amendment | 333-297487 | 0001185185-26-003353 |
| 2026-07-29 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1903784/000118518526003162/0001185185-26-003162-index.htm) Amendment | 333-297487 | 0001185185-26-003162 |
| 2026-07-15 | [S-1](https://www.sec.gov/Archives/edgar/data/1903784/000118518526002985/0001185185-26-002985-index.htm) Registration filed | 333-297487 | 0001185185-26-002985 |
| 2026-02-20 | [DRS](https://www.sec.gov/Archives/edgar/data/1903784/000118518526000633/0001185185-26-000633-index.htm) Draft made public | 377-09094 | 0001185185-26-000633 |

[All filings of this company](https://equitycapital.markets/filings?cik=1903784) · [CSV](https://equitycapital.markets/filings.csv?cik=1903784)

---
Source page: https://equitycapital.markets/company/1903784 · Data: U.S. SEC EDGAR · CC BY 4.0